Latest News

Experimental antibody shows early promise for treatment of childhood tumor

Tumors shrank or disappeared and disease progression was temporarily halted in 15 children with advanced neuroblastoma enrolled in a safety study of an experimental antibody. Four patients are still alive after more than two-and-a-half years and without additional treatment. Neuroblastoma is a cancer of the sympathetic nervous system. It is the most common cancer diagnosed in the first year of life and accounts for 7 to 10 percent of childhood cancers.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Neuroscientists identify new way several brain areas communicate

  • Air pollution linked to slower cognitive development in children

  • Creative genius driven by distraction

  • Republicans trust science -- except when it comes to health insurance and gay adoption

  • Alcohol screening, intervention for risky drinking: A guide for physicians

  • Anxious people more apt to make bad decisions amid uncertainty

  • Myelin-maker: How an FDA-approved drug boosts myelin synthesis

  • Vaccine skeptics aren't swayed by emotional scare tactics

  • Administering Sedatives for Patients Receiving General Anesthesia Questioned

  • Examination of prior authorization policies for antipsychotic prescribing to children

  •